Dr. Joshi brings a wealth of expertise driving research in the field of headache and migraine. Before becoming Director of Headache Medicine and Clinical Research at COMMUNITY NEUROSCIENCE SERVICES, Dr. Joshi completed his Neurology Residency at the Beth Israel Medical Center and was Instructor of Neuroscience at the Harvard Medical School. His research in headache medicine has been recognized with the “Frontiers in Headache Research” Scholarship Award from the American Headache Society.
Dr. Joshi shares our excitement, stating:
“I am excited about the potential of Brightmind.AI’s technology to revolutionize the way we treat migraines and other neurological disorders. Among providers and clinical experts, neuromodulation for migraine experiences growing interest due to its outstanding safety profile while offering at least comparable or even superior clinical outcomes to traditional medications.”
With Dr. Joshi on board, we are more confident than ever in bringing innovative, effective treatments to those suffering from neurological conditions.